glp-1-directed nmda receptor antagonism for obesity treatment Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies GLP-1 Receptor Agonists and Research

Glucagon agonism can affect hepatic glucose output and lipid metabolism, and its long-term effects on liver function and cardiovascular risk require careful evaluation

Type 2 diabetes: They are used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes

We dont just prescribe medications and send you on your way

We definitely are seeing patients who are requesting methods for lifting and tightening after weight loss with these medications. The term Ozempic face started trending at the end of 2023 to describe the cosmetic effects of sudden weight loss to the face and jowls

Another recommendation includes changes to the meal structure

The gradual dose-escalation protocol is specifically designed to minimise these effects